πŸ‡ΊπŸ‡Έ FDA
Patent

US 12291565

Tau binding compounds

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 12291565 (Tau binding compounds) held by VOYAGER THERAPEUTICS, INC. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K2039/545, A61P, A61P25/28